Genome sequencing of HCC cohorts has revealed many genomic alterations, such as mutations of TP53, CTNNB1, and AXIN1, copy number alterations of CDKN2A/CDKN2B, and multiple alterations of TERT [9–14]. The gene discussed is TP53; the disease is hepatocellular carcinoma.